Antiviral OTC Medications

The USDA APHIS is issuing Solicitation 12639526Q0214 as a Request for Quote (RFQ) for a restock of two antiviral medications: Zanamivir (Relenza) inhalation powder and Oseltamivir (Tamiflu) oral capsules. All quotations must be submitted on the attached SF 1449, include pricing for every line item, and be delivered FOB destination to the USDA APHIS address in Minneapolis, MN no later than September 24 2026 (early deliveries are acceptable). The award will be made to the offeror representing the best value, evaluated under FAR 12.203/12.204 using a “lowest price technically acceptable” approach; only the lowest‑priced offer will be examined for technical acceptability and past‑performance, with subsequent offers considered if the lowest fails those criteria. This acquisition is a Total Small Business Set‑Aside (NAICS 325412, size standard 1,300 employees) and is eligible for a range of small‑business designations, including SDVOSB, HUBZone, WOSB, and EDWOSB. The contract is a DPAS‑rated order (15 CFR 700). Offerors should reference the incorporated FAR clauses (52.212‑1, ‑4, ‑3, ‑5) and follow the protest procedures outlined for USDA. Technical inquiries may be directed to Cody Grey (603‑833‑0842, cody.grey@usda.gov).

Notice ID

bc45644a9fc349599ca2484a7b24a0c2

Solicitation Number

12639526Q0214

NAICS Code

325412

Classification Code

6505